山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (6): 1-8.doi: 10.6040/j.issn.1671-7554.0.2024.0265
• 基础医学 •
刘海霞,皇甫莎莎,桑晓玉,崔东清,毕建忠,王萍
LIU Haixia, HUANGFU Shasha, SANG Xiaoyu, CUI Dongqing, BI Jianzhong, WANG Ping
摘要: 目的 探讨间充质干细胞(mesenchymal stem cells, MSCs)治疗对实验性自身免疫性脑脊髓炎(experimental autoimmune encephalomyelitis, EAE)小鼠铁死亡状况及关键调控蛋白表达的影响。 方法 记录每日小鼠体质量和行为表现,切片染色观察小鼠脊髓中炎症及脱髓鞘情况。通过检测还原型谷胱甘肽还原酶(reduced glutathione, GSH)、丙二醛(malondialdehyde, MDA)及总超氧化物歧化酶(total superoxide dismutase, T-SOD)观察小鼠组织中铁死亡状况,并检测转铁蛋白受体-1(transferrin receptor 1, TFR1)、酰基辅酶A合酶-4(acyl-CoA synthetase long-chain family 4, ACSL4)、谷胱甘肽过氧化酶-4(glutathione peroxidase 4, GPX4)及铁死亡抑制蛋白1(ferroptosis suppressor protein, FSP1)等调控蛋白的表达。 结果 MSCs可以有效改善EAE小鼠体质量下降和症状表现。病理水平上,MSCs注射可以改善小鼠脊髓中炎细胞浸润及脱髓鞘。MSCs注射后,EAE小鼠脊髓和脑GSH含量升高(P<0.01,P<0.05)、脊髓T-SOD活力升高(P<0.01),脑中MDA含量下降(P<0.05)。MSCs治疗可以降低 EAE小鼠脊髓和脑中TFR1(P<0.05,P<0.01)、ACSL4蛋白表达(P<0.05, P<0.001),提高脊髓和脑中FSP1蛋白表达(P均<0.05)和脑中GPX4蛋白表达(P<0.05)。 结论 MSCs通过调节铁代谢、脂代谢和促进活性氧清除来抑制EAE小鼠中铁死亡,发挥治疗作用。
中图分类号:
[1] Kobelt G, Thompson A, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe[J]. Mult Scler, 2017, 23(8): 1123-1136. [2] Dangond F, Donnelly A, Hohlfeld R, et al. Facing the urgency of therapies for progressive MS-a Progressive MS Alliance proposal[J]. Nat Rev Neurol, 2021, 17(3): 185-192. [3] Andrzejewska A, Dabrowska S, Lukomska B, et al. Mesenchymal stem cells for neurological disorders[J]. Adv Sci, 2021, 8(7): 2002944. doi:10.1002/advs.202002944. [4] Jhelum P, Zandee S, Ryan F, et al. Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS[J]. Acta Neuropathol Commun, 2023, 11(1): 121. doi:10.1186/s40478-023-01617-7. [5] Charabati M, Wheeler MA, Weiner HL, et al. Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting[J]. Cell, 2023, 186(7): 1309-1327. [6] Curko-Cofek B, Kezele TG, Marini c J, et al. Chronic iron overload induces gender-dependent changes in iron homeostasis, lipid peroxidation and clinical course of experimental autoimmune encephalomyelitis[J]. Neurotoxicology, 2016, 57: 1-12. doi:10.1016/j.neuro.2016.08.014. [7] Grant SM, Wiesinger JA, Beard JL, et al. Iron-deficient mice fail to develop autoimmune encephalomyelitis[J]. J Nutr, 2003, 133(8): 2635-2638. [8] Luoqian JY, Yang WY, Ding XL, et al. Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis[J]. Cell Mol Immunol, 2022, 19(8): 913-924. [9] Duarte-Silva E, Meuth SG, Peixoto CA. The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis[J]. Front Immunol, 2023, 14: 1137635. doi:10.3389/fimmu.2023.1137635. [10] Jakimovski D, Bittner S, Zivadinov R, et al. Multiple sclerosis[J]. Lancet, 2024, 403(10422): 183-202. [11] Lindsay SL, Molda AM, MacLellan LM, et al. Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination[J]. Acta Neuropathol Commun, 2022, 10(1): 12. doi:10.1186/s40478-022-01316-9. [12] de Freitas CL, Polonio CM, Brandão WN, et al. Human fallopian tube-derived mesenchymal stem cells inhibit experimental autoimmune encephalomyelitis by suppressing Th1/Th17 activation and migration to central nervous system[J]. Stem Cell Rev Rep, 2022, 18(2): 609-625. [13] Gavasso S, Kråkenes T, Olsen H, et al. The therapeutic mechanisms of mesenchymal stem cells in MS-a review focusing on neuroprotective properties[J]. Int J Mol Sci, 2024, 25(3): 1365. doi:10.3390/ijms25031365. [14] Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications[J]. Cell, 2022, 185(14): 2401-2421. [15] Chen JJ, Galluzzi L. Fighting resilient cancers with iron[J]. Trends Cell Biol, 2018, 28(2): 77-78. [16] 唐文诚, 何清, 李俊峰, 等. 川芎嗪通过抑制炎症反应和铁死亡减轻对乙酰氨基酚所致肝损伤[J]. 世界中医药, 2023, 18(24): 3512-3517. TANG Wencheng, HE Qing, LI Junfeng, et al. Ligustrazine alleviates acetaminophen-induced liver injury by inhibiting inflammatory response and ferroptosis[J]. World Chinese Medicine, 2023, 18(24): 3512-3517. [17] Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature, 2019, 575(7784): 693-698. [18] Hu CL, Nydes M, Shanley KL, et al. Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis[J]. J Neurochem, 2019, 148(3): 426-439. [19] Fan JY, Han YS, Sun HH, et al. Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2[J]. Biomed Pharmacother, 2023, 162: 114593. doi:10.1016/j.biopha.2023.114593. [20] 朱月新. 人脐带间充质干细胞通过激活Nrf2调控铁死亡改善2型糖尿病肾病的机制研究[D]. 长春: 吉林大学, 2023. [21] Wang H, Sun Y, Xiao FJ, et al. Mesenchymal stem cells ameliorate DSS-induced experimental colitis by modulating the gut microbiota and MUC-1 pathway[J]. J Inflamm Res, 2023, 16: 2023-2039. doi:10.2147/JIR.S402592. [22] Xu JF, Zhang MH, Liu F, et al. Mesenchymal stem cells alleviate post-resuscitation cardiac and cerebral injuries by inhibiting cell pyroptosis and ferroptosis in a swine model of cardiac arrest[J]. Front Pharmacol, 2021, 12: 793829. doi:10.3389/fphar.2021.793829. [23] 姜懿洋, 刘帅, 张静涛, 等. 中医药通过诱导铁死亡治疗肺癌的研究进展[J]. 中医药学报, 2024, 52(3): 100-108. JIANG Yiyang, LIU Shuai, ZHANG Jingtao, et al. Progress in the treatment of lung cancer by iron death induced by traditional Chinese medicine[J]. Acta Chinese Medicine and Pharmacology, 2024, 52(3): 100-108. [24] Sindrilaru A, Peters T, Wieschalka S, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice[J]. J Clin Invest, 2011, 121(3): 985-997. [25] van San E, Debruyne AC, Veeckmans G, et al. Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression[J]. Cell Death Differ, 2023, 30(9): 2092-2103. [26] 黄美玲. 内质网应激PERK信号通路对糖尿病肾病模型铁死亡的影响及胎盘间充质干细胞的干预机制研究[D]. 南昌: 南昌大学, 2023. [27] Shao CL, Chen Y, Yang TY, et al. Mesenchymal stem cell derived exosomes suppress neuronal cell ferroptosis via lncGm36569/miR-5627-5p/FSP1 axis in acute spinal cord injury[J]. Stem Cell Rev Rep, 2022, 18(3): 1127-1142. [28] Diggle CP. In vitro studies on the relationship between polyunsaturated fatty acids and cancer: tumour or tissue specific effects?[J]. Prog Lipid Res, 2002, 41(3): 240-253. [29] Andrews NC, Schmidt PJ. Iron homeostasis[J]. Annu Rev Physiol, 2007, 69: 69-85. doi:10.1146/annurev.physiol.69.031905.164337. [30] Feng HZ, Schorpp K, Jin J, et al. Transferrin receptor is a specific ferroptosis marker[J]. Cell Rep, 2020, 30(10): 3411-3423. [31] 闫霖, 陆珏秀, 罗颖, 等. BM-MSCs来源外泌体介导铁死亡减轻大鼠心肌细胞系H9c2缺氧/复氧损伤[J]. 基础医学与临床, 2023, 43(5): 771-776. YAN Lin, LU Juexiu, LUO Ying, et al. Protective effect of BM-MSCs-derived exosome-mediated ferroptosis against anoxia-reoxygenation injury in rat cardiomyoblastl cell line H9c2[J]. Basic and Clinical Medicine, 2023, 43(5): 771-776. [32] Zarruk JG, Berard JL, Passos dos Santos R, et al. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation[J]. Neurobiol Dis, 2015, 81: 93-107. doi:10.1016/j.nbd.2015.02.001. [33] Juurlink BH, Thorburne SK, Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress[J]. Glia, 1998, 22(4): 371-378. [34] Qin DQ, Li D, Wang CJ, et al. Ferroptosis and central nervous system demyelinating diseases[J]. J Neurochem, 2023, 165(6): 759-771. [35] Li XY, Chu YJ, Ma R, et al. Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis[J]. J Neuroimmunol, 2022, 373: 577995. doi:10.1016/j.jneuroim.2022.577995. |
[1] | 沈海涛,乔亚琴,董萍,路燕. Toll样受体4调控的程序性坏死和铁死亡对对乙酰氨基酚肝损伤的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 1-8. |
[2] | 沈飞飞,李栋,刘玲红,鞠秀丽. 小肠黏膜下层处理的间充质干细胞片促进伤口愈合[J]. 山东大学学报 (医学版), 2024, 62(4): 68-77. |
[3] | 赵元元,路军涛,吴小华. 人脐带间充质干细胞外泌体miR-100对多囊卵巢综合征患者颗粒细胞炎症的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 51-58. |
[4] | 王成,张淑卉,闫娜,孟林林,陈良志,刘庆华. 脐带间充质干细胞治疗中晚期博来霉素诱导小鼠肺间质纤维化的机制[J]. 山东大学学报 (医学版), 2023, 61(10): 17-22. |
[5] | 侯少瑾,王云凤,曹丽丽,刘学伍,赵秀鹤,王胜军. 视神经脊髓炎谱系疾病53例与多发性硬化11例的脑脊液检测比较[J]. 山东大学学报 (医学版), 2023, 61(1): 32-37. |
[6] | 姜卉,魏甜,李建平,王聪. 葛根素对索拉非尼心肌毒性的保护及作用机制[J]. 山东大学学报 (医学版), 2022, 60(8): 14-22. |
[7] | 冯宝民,王舟,徐晗,李佳存,于乔文,修建军. 抗髓鞘少突胶质细胞糖蛋白IgG抗体相关疾病临床及影像特征[J]. 山东大学学报 (医学版), 2022, 60(3): 45-50. |
[8] | 张高瑞,张玉婷,赵雨萱,王方青,于德新. MnFe2O4@CNS纳米探针在胰腺癌诊疗一体化中的价值[J]. 山东大学学报 (医学版), 2021, 59(4): 48-55. |
[9] | 鞠秀丽. 间充质干细胞治疗新型冠状病毒肺炎的潜在机制和研究进展[J]. 山东大学学报 (医学版), 2020, 58(3): 32-37. |
[10] | 徐焱焱,颜贝,王锐,王红燕. 经血间充质干细胞通过IGF-1信号通路改善小鼠卵巢早衰[J]. 山东大学学报 (医学版), 2020, 58(2): 13-20. |
[11] | 赵鸿渐,周继军,苏庆亮,赵硕,李玉明. 胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤进展的相关性[J]. 山东大学学报 (医学版), 2019, 57(9): 69-73. |
[12] | 张志慧,刘延国,肖丰启,马道新,王秀问. 顺铂对肿瘤间充质干细胞中IL-6表达的调控及p38MAPK通路参与机制[J]. 山东大学学报 (医学版), 2019, 57(3): 1-6. |
[13] | 侯巧妮,马会明,相丽,何艳桃,徐仙,陈冬梅,张雪玉. 人胎盘间充质干细胞移植对化疗所致卵巢早衰大鼠卵巢功能的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 52-60. |
[14] | 黄金献,李栋,李聪,时庆,鞠秀丽. 三维和二维培养的脐带间充质干细胞DNA甲基化水平比较[J]. 山东大学学报 (医学版), 2019, 57(11): 1-8. |
[15] | 郭配,李秀华,张晓韬,何天齐,朱梅佳,唐吉友,赵张宁,毛飞. 伴有睡眠障碍帕金森病患者的睡眠特征及其影响因素[J]. 山东大学学报 (医学版), 2018, 56(4): 76-80. |
|